Cisbio
Mid Cap
Elevare la qualità della vita
Cedute
Cisbio operates mostly in Life Sciences Drug Discovery. It also has a small In-Vitro Diagnostics business unit. It serves clients through both a direct sales organization and distributors.
It has 3 overseas subsidiaries (USA, China, Japan). Life Sciences activities serve big pharmas as well as biotechs and university research institutes. They focus on developing reagents at early phases of the biopharma R&D value chain, when biotechs/pharmas perform series of key tests to bring therapeutic candidates to clinical trials. The group IVD activities manufacture reagents to perform tests on biological samples (e.g.: blood, urine, tissues) to diagnose diseases in medical laboratories.
45m€
Fatturato
210
Dipendenti
June 2016
Anno di ingresso
← → Naviga tra le aziende